Additional value of MRI-detected EMVI scoring system in rectal cancer: applicability in predicting synchronous metastasis
- PMID: 32116150
- DOI: 10.1177/0300891620901745
Additional value of MRI-detected EMVI scoring system in rectal cancer: applicability in predicting synchronous metastasis
Abstract
Introduction: Extramural vascular invasion (EMVI) has been recommended as an independent prognostic factor for poor overall survival rate in rectal cancer and can be used as a potential biomarker. Early prediction of prevalence of synchronous metastasis can elevate the disease-free survival rate. We aimed to evaluate the magnetic resonance imaging (MRI)-detected EMVI (mrEMVI) scoring system in predicting distant metastasis in T3 rectal cancer.
Methods: Patients with postoperative histopathologically confirmed T3 rectal cancer without previous treatment from July 2014 to December 2015 were enrolled in this study. Two blinded radiologists evaluated mrEMVI status. mrEMVI was categorized as EMVI-positive or EMVI-negative in T2-weighted images using an mrEMVI scoring system. The results, along with other clinical characteristics (age, sex, tumor location, MRI-detected distance of mesorectal extension, lymphatic invasion, perineural invasion, mrEMVI score, and carcinoembryonic antigen [CEA]), were then correlated with synchronous metastases to determine the risk factors using univariate and multivariate analysis.
Results: Of 180 patients, 38 were confirmed to be mrEMVI-positive, 142 mrEMVI-negative. There were 34 patients with synchronous metastasis, of whom 25 were mrEMVI-positive and 9 were mrEMVI-negative. Three factors were significantly associated with synchronous metastasis: mrEMVI (p = 0.001; odds ratio = 8.665), histopathologic lymphatic invasion (p = 0.001; odds ratio = 12.940), and preoperative CEA (p = 0.026; odds ratio = 4.124). mrEMVI score 4 was more likely for synchronous metastasis (p = 0.044; odds ratio = 9.429) than mrEMVI score 3 in rectal cancer.
Conclusions: mrEMVI positivity is an independent risk factor for synchronous distant metastasis in rectal cancer. mrEMVI score 4 is a stronger risk factor for synchronous metastasis than mrEMVI score 3 in rectal cancer.
Keywords: Distant metastasis; magnetic resonance imaging–detected extramural vascular invasion; rectal cancer.
Similar articles
-
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.Br J Cancer. 2017 Jun 6;116(12):1513-1519. doi: 10.1038/bjc.2017.99. Epub 2017 Apr 27. Br J Cancer. 2017. PMID: 28449006 Free PMC article. Review.
-
MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer.Eur Radiol. 2015 May;25(5):1347-55. doi: 10.1007/s00330-014-3527-9. Epub 2014 Dec 13. Eur Radiol. 2015. PMID: 25500963
-
The prognostic importance of MRI detected extramural vascular invasion (mrEMVI) in locally advanced rectal cancer.Int J Colorectal Dis. 2020 Oct;35(10):1849-1854. doi: 10.1007/s00384-020-03632-9. Epub 2020 Jun 2. Int J Colorectal Dis. 2020. PMID: 32488420
-
Clinical value of MRI-detected extramural venous invasion in rectal cancer.J Dig Dis. 2017 Jan;18(1):2-12. doi: 10.1111/1751-2980.12439. J Dig Dis. 2017. PMID: 28009094 Review.
-
The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.Sci Rep. 2019 Aug 29;9(1):12523. doi: 10.1038/s41598-019-47466-0. Sci Rep. 2019. PMID: 31467313 Free PMC article.
Cited by
-
Toxicity, Disease Control, and Survival Outcomes of Intensified Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Single-Institution Study.Cancer Manag Res. 2023 May 8;15:387-398. doi: 10.2147/CMAR.S398592. eCollection 2023. Cancer Manag Res. 2023. PMID: 37187801 Free PMC article.
-
Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer.Clin Med Insights Oncol. 2024 Feb 5;18:11795549241227423. doi: 10.1177/11795549241227423. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 38322665 Free PMC article.
-
The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer.Cancers (Basel). 2024 Sep 9;16(17):3111. doi: 10.3390/cancers16173111. Cancers (Basel). 2024. PMID: 39272969 Free PMC article. Review.
-
Extramural vascular invasion nomogram before radical resection of rectal cancer based on magnetic resonance imaging.Front Oncol. 2023 Mar 9;12:1006377. doi: 10.3389/fonc.2022.1006377. eCollection 2022. Front Oncol. 2023. PMID: 36968215 Free PMC article.
-
Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study.BMC Med Imaging. 2022 Apr 28;22(1):78. doi: 10.1186/s12880-022-00810-9. BMC Med Imaging. 2022. PMID: 35484509 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical